Mirae Asset Global ETFs Holdings
PRLD icon

Mirae Asset Global ETFs Holdings’s Prelude Therapeutics PRLD Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio PRLD Stock Details PRLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.1K Buy
+12,784
New +$55.6K ﹤0.01% 2970
2025
Q2 		– Sell
-7,887
Closed -$6.06K – 3181
2025
Q1 		$6.06K Buy
7,887
+312
+4% +$291 ﹤0.01% 3035
2024
Q4 		$9.66K Buy
7,575
+304
+4% +$403 ﹤0.01% 3032
2024
Q3 		$15.1K Sell
7,271
-864
-11% -$4K ﹤0.01% 3028
2024
Q2 		$31K Buy
+8,135
New +$33.1K ﹤0.01% 2867

Other funds holding PRLD

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's PRLD Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Prelude Therapeutics (PRLD) in Q2 2026: 12,784 shares worth $68.1K. The stake represents ﹤0.01% of the portfolio and ranks #2970 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in PRLD as recently as Q1 2025.

Mirae Asset Global ETFs Holdings first reported a position in PRLD in Q2 2024 and has held it in 5 quarters since. 75 funds tracked by Wall St. Rank hold PRLD as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 12,784 shares of Prelude Therapeutics worth $68.1K as of Q2 2026.
  • Prelude Therapeutics was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
  • Prelude Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2970 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Prelude Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 75 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.